Free Trial

Agilent Technologies (A) Stock Forecast & Price Target

Agilent Technologies logo
$123.86 -2.88 (-2.27%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Agilent Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
6
Buy
6

Based on 12 Wall Street analysts who have issued ratings for Agilent Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 6 have given a hold rating, and 6 have given a buy rating for A.

Consensus Price Target

$139.25
12.43% Upside
According to the 12 analysts' twelve-month price targets for Agilent Technologies, the average price target is $139.25. The highest price target for A is $165.00, while the lowest price target for A is $116.00. The average price target represents a forecasted upside of 12.43% from the current price of $123.86.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for A and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agilent Technologies and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

A Analyst Ratings Over Time

TypeCurrent Forecast
9/12/24 to 9/12/25
1 Month Ago
8/13/24 to 8/13/25
3 Months Ago
6/14/24 to 6/14/25
1 Year Ago
9/13/23 to 9/12/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
8 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$139.25$139.77$140.15$141.60
Forecasted Upside12.43% Upside16.20% Upside19.82% Upside3.79% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyHold

A Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

A Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Agilent Technologies Stock vs. The Competition

TypeAgilent TechnologiesMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside9.75% Upside17,118.86% Upside9.66% Upside
News Sentiment Rating
Positive News

See Recent A News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/29/2025Barclays
3 of 5 stars
Luke Sergott
Luke Sergott
Not Rated
Reiterated RatingEqual Weight$125.00+0.24%
8/28/2025Robert W. Baird
2 of 5 stars
Boost TargetOutperform$141.00 ➝ $142.00+15.54%
8/28/2025Wells Fargo & Company
3 of 5 stars
Boost TargetOverweight$135.00 ➝ $140.00+14.16%
8/28/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetIn-Line$130.00 ➝ $128.00+7.72%
5/30/2025Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$135.00+19.78%
5/29/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetNeutral$150.00 ➝ $130.00+13.99%
5/29/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$160.00 ➝ $155.00+34.39%
5/29/2025TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$150.00+29.52%
4/21/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetHold$135.00 ➝ $116.00+16.44%
12/19/2024Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$165.00+23.96%
12/13/2024Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetNeutral$153.00 ➝ $150.00+8.93%
11/26/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetMarket Perform$140.00 ➝ $135.00+1.41%
8/26/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuy$151.00+7.19%
6/27/2024Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformPeer Perform
3/26/2024Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOutperform$67.00 ➝ $90.00-38.30%
12/7/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$128.00 ➝ $145.00+12.47%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:27 PM ET.


Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 8, 2025. Please send any questions or comments about these Agilent Technologies pros and cons to contact@marketbeat.com.

Agilent Technologies
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

  • The current stock price is around $128, reflecting a stable performance in the market.
  • Agilent Technologies, Inc. reported a revenue increase of over 10% compared to the same quarter last year, indicating strong growth potential.
  • The company has a solid market capitalization of approximately $36 billion, suggesting a robust financial position.
  • Analysts have a consensus rating of "Moderate Buy" for the stock, with several recent upgrades in price targets, indicating positive market sentiment.
  • Agilent Technologies, Inc. operates in diverse segments such as Life Sciences and Diagnostics, which can provide resilience against market fluctuations.

Agilent Technologies
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

  • Some analysts have downgraded their price targets, with UBS Group lowering theirs from $150 to $130, which may indicate concerns about future performance.
  • The stock has shown volatility, with a 12-month high of $153.84 and a low of $96.43, suggesting potential risks for investors.
  • The price-to-earnings ratio is around 30, which may be considered high, indicating that the stock could be overvalued compared to its earnings.
  • Recent earnings reports have met expectations but not exceeded them, which may signal a lack of significant growth momentum.
  • The company has a beta of 1.24, indicating that its stock price is more volatile than the market, which could pose risks for conservative investors.

A Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Agilent Technologies is $139.25, with a high forecast of $165.00 and a low forecast of $116.00.

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" A shares.

According to analysts, Agilent Technologies's stock has a predicted upside of 12.43% based on their 12-month stock forecasts.

Agilent Technologies has been rated by research analysts at Barclays, Evercore ISI, Robert W. Baird, and Wells Fargo & Company in the past 90 days.

Analysts like Agilent Technologies less than other "medical" companies. The consensus rating score for Agilent Technologies is 2.50 while the average consensus rating score for "medical" companies is 2.78. Learn more on how A compares to other companies.


This page (NYSE:A) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners